Effect of BQ 123 in early brain injuries caused by subarachnoid hemorrhage in rats

Chaowang An,Yaning Zhao,Yao Liu,Xu Zhao,Jianmin Li,Changxiang Chen,Na Dou,Chengjing Xue
2017-01-01
Abstract:Objective: We discussed the treatment effect of BQ-123 on subarachnoid hemorrhage (SAH) in rats and analyzed the working mechanism. Method: SD rats were randomly divided into sham operation group, SAH group, high-dose BQ-123 group and low-dose BQ-123 group. Double hemorrhage injection was used to produce SAH model in rats and morphological changes were observed under the optical microscope and electron microscope. Hippocampal expressions of phosphatidylinositol 3-kinase (PI3-K), protein kinase B (PKB/Akt) and mammalian target of rapamycin (mTOR) were detected by immunohistochemistry and Real-time PCR. Learning and memory capacities of rats were determined by the shuttle box paradigm. Result: Compared with the sham operation group, SAH group showed severe neuronal damage in the hippocampus, with an upregulation of phosphorylated PI3-K, Akt and mTOR. SAH group had less surviving neurons and a decline in learning and memory capacities (P<0.05). Compared with SAH group, the BQ-123 treatment groups showed alleviated neuronal damage, upregulated PI3-K and Akt, downregulated mTOR, more surviving neurons and improved learning and memory capacities. These changes were more obvious in the high-dose group (P<0.05). Conclusion: BQ-123 has a good therapeutic effect in early brain injury after SAH, possibly by regulating the PI3K/Akt and inhibing mTOR activity.
What problem does this paper attempt to address?